• About Us
• Technology
• Partnering
• Diseases
• Product Pipeline
• Investors and media
• Careers
• Contact

• 
• 
• 
• 
• 
• 
• Dansk

• 2008

  28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...

  Read More >

• Product Pipeline

  Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...

  Read More >

Zealand Pharma

Zealand Pharma is a biopharmaceutical company dedicated to the discovery and development of innovative peptide-based drugs. The products target diseases and symptoms of significant unmet clinical need and commercial potential.

Since 1999, Zealand’s scientists have built a pipeline that includes one compound in clinical phase III development, two compounds in clinical phase II development and three compounds in clinical phase I development. In addition, two compounds are in pre-clinical development.

As part of the Company’s operations, Zealand Pharma has formed clinical development partnerships with leading pharmaceutical companies Sanofi-Aventis and Wyeth.

Zealand Pharma is based in Copenhagen and has approximately 65 employees.

Annual Report 2007